Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ata Mahmoodpoor

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Life Sciences|December 14, 2020
Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing miceShima Bastaki, Surendar Aravindhan, Nasrin Ahmadpour Saheb, et al.
Life Sciences|October 2, 2025
Retraction notice to "Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice" [Life Sci. 266 (2021) 118847]Shima Bastaki, Surendar Aravindhan, Nasrin Ahmadpour Saheb, et al.
Journal of Cellular Physiology|November 15, 2019
MicroRNAs in breast cancer: Roles, functions, and mechanism of actionsMaryam Abolghasemi, Sadra Samavarchi Tehrani, Tooba Yousefi, et al.
Reproductive Biology|February 27, 2021
Will stem cells from fat and growth factors from blood bring new hope to female patients with reproductive disorders?Amir Valizadeh, Samira Asghari, Sepideh Bastani, et al.
Pharmaceutical Research|June 17, 2022
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer ModelAsal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Molecular Immunology|August 15, 2021
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progressionAta Mahmoodpoor, Maryam Hosseini, Sadegh Soltani-Zangbar, et al.
Pharmaceutical Research|December 26, 2023
Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer ModelAsal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Journal of Cellular Physiology|January 18, 2020
Critical roles of long noncoding RNAs in breast cancerMaryam Abolghasemi, Sadra S Tehrani, Tooba Yousefi, et al.
Cytokine|February 11, 2021
Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathyRoza Motavalli, Jalal Etemadi, Mohammad Sadegh Soltani-Zangbar, et al.
Reproductive Medicine and Biology|March 23, 2023
Sirolimus- and cyclosporine-loaded nanostructured lipid carriers: Development, characterization, and in vitro evaluation in T-cell profiles of patients with a history of recurrent pregnancy lossForough Parhizkar, Mehdi Yousefi, Mohammad Sadegh Soltani-Zangbar, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Life Sciences|December 14, 2020
Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing miceShima Bastaki, Surendar Aravindhan, Nasrin Ahmadpour Saheb, et al.
Life Sciences|October 2, 2025
Retraction notice to "Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice" [Life Sci. 266 (2021) 118847]Shima Bastaki, Surendar Aravindhan, Nasrin Ahmadpour Saheb, et al.
Journal of Cellular Physiology|November 15, 2019
MicroRNAs in breast cancer: Roles, functions, and mechanism of actionsMaryam Abolghasemi, Sadra Samavarchi Tehrani, Tooba Yousefi, et al.
Reproductive Biology|February 27, 2021
Will stem cells from fat and growth factors from blood bring new hope to female patients with reproductive disorders?Amir Valizadeh, Samira Asghari, Sepideh Bastani, et al.
Pharmaceutical Research|June 17, 2022
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer ModelAsal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Molecular Immunology|August 15, 2021
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progressionAta Mahmoodpoor, Maryam Hosseini, Sadegh Soltani-Zangbar, et al.
Pharmaceutical Research|December 26, 2023
Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer ModelAsal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Journal of Cellular Physiology|January 18, 2020
Critical roles of long noncoding RNAs in breast cancerMaryam Abolghasemi, Sadra S Tehrani, Tooba Yousefi, et al.
Cytokine|February 11, 2021
Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathyRoza Motavalli, Jalal Etemadi, Mohammad Sadegh Soltani-Zangbar, et al.
Reproductive Medicine and Biology|March 23, 2023
Sirolimus- and cyclosporine-loaded nanostructured lipid carriers: Development, characterization, and in vitro evaluation in T-cell profiles of patients with a history of recurrent pregnancy lossForough Parhizkar, Mehdi Yousefi, Mohammad Sadegh Soltani-Zangbar, et al.
Pageof 23